Journal of obstetrics and gynaecology Canada最新文献

英文中文

Innovative 3-Dimensional Imaging in Preoperative Evaluation for Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer—A Pilot Study 创新三维成像在复发性卵巢癌二次清宫手术术前评估中的应用：一项试点研究。

IF 2 Q2 OBSTETRICS & GYNECOLOGY

Journal of obstetrics and gynaecology Canada

Pub Date : 2025-01-01 DOI: 10.1016/j.jogc.2024.102714

Michael Lavie MD , Jumana Joubran MD , Amit Benady MD , Phillip Berman MA , Nadav Michaan MD , Dan Grisaru MD , Ido Laskov MD

Objective

The efficacy of secondary cytoreductive surgery (SCS) in recurrent ovarian cancer remains controversial, necessitating meticulous preoperative planning. While three-dimensional (3D) imaging has transformed surgical approaches in various disciplines, its application in gynaecologic oncology is nascent. This study introduces a novel investigation employing preoperative 3D modelling in SCS preparation.

Methods

A retrospective analysis was undertaken at a university-affiliated tertiary medical centre, examining patients who underwent SCS for recurrent ovarian cancer between 2017 and 2022. Patients were stratified into 2 cohorts: those with preoperative CT-based 3D imaging (group A) and those without (group B). Demographic profiles, clinical data, and surgical outcomes were compared between the groups.

Results

Among the 76 identified patients, 18 were deemed suitable for surgery, with 7 in group A undergoing preoperative 3D modelling. Demographics encompassing age and performance status were consistent across both groups, while Serous histology was more prominent in group B. Although operative metrics and collaborative endeavours exhibited no statistically significant variance, the attainment of optimal debulking with no residual disease (R0) was substantially higher in group A (100%) compared to group B (54%), with a significance level of P = 0.05.

Conclusion

CT-based 3D modelling in the preoperative phase of SCS for ovarian cancer shows potential for enhancing surgical planning. While this pioneering research highlights the potential benefits of integrating 3D imaging into gynaecologic oncology, the limitations of this retrospective study imply that these findings are primarily hypothesis-generating. Further prospective studies are necessary to validate the impact.

导言：复发性卵巢癌二次细胞减灭术（SCS）的疗效仍存在争议，因此必须制定周密的术前计划。虽然三维成像技术已经改变了各学科的手术方法，但在妇科肿瘤学中的应用却刚刚起步。本研究介绍了一项在 SCS 准备过程中采用术前 3D 建模的新调查：在一所大学附属三级医疗中心进行了一项回顾性分析，研究对象为 2017 年至 2022 年期间因复发性卵巢癌接受 SCS 治疗的患者。患者被分为两组：术前CT三维成像组（A组）和无CT三维成像组（B组）。对两组患者的人口统计学特征、临床数据和手术结果进行了比较：结果：在 76 名确定的患者中，18 人被认为适合手术，其中 A 组中有 7 人进行了术前三维建模。虽然手术指标和合作努力在统计学上没有显著差异，但与 B 组（54%）相比，A 组（100%）达到无残留疾病（R0）的最佳清除率要高得多，显著性水平为 P = 0.05：基于 CT 的三维建模在卵巢癌二次细胞减灭术的术前阶段显示出加强手术规划的潜力。虽然这项开创性的研究强调了将三维成像整合到妇科肿瘤学中的潜在益处，但这项回顾性研究的局限性意味着这些发现主要是假设性的。有必要开展进一步的前瞻性研究来验证其影响。

{"title":"Innovative 3-Dimensional Imaging in Preoperative Evaluation for Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer—A Pilot Study","authors":"Michael Lavie MD , Jumana Joubran MD , Amit Benady MD , Phillip Berman MA , Nadav Michaan MD , Dan Grisaru MD , Ido Laskov MD","doi":"10.1016/j.jogc.2024.102714","DOIUrl":"10.1016/j.jogc.2024.102714","url":null,"abstract":"<div><h3>Objective</h3><div>The efficacy of secondary cytoreductive surgery (SCS) in recurrent ovarian cancer remains controversial, necessitating meticulous preoperative planning. While three-dimensional (3D) imaging has transformed surgical approaches in various disciplines, its application in gynaecologic oncology is nascent. This study introduces a novel investigation employing preoperative 3D modelling in SCS preparation.</div></div><div><h3>Methods</h3><div>A retrospective analysis was undertaken at a university-affiliated tertiary medical centre, examining patients who underwent SCS for recurrent ovarian cancer between 2017 and 2022. Patients were stratified into 2 cohorts: those with preoperative CT-based 3D imaging (group A) and those without (group B). Demographic profiles, clinical data, and surgical outcomes were compared between the groups.</div></div><div><h3>Results</h3><div>Among the 76 identified patients, 18 were deemed suitable for surgery, with 7 in group A undergoing preoperative 3D modelling. Demographics encompassing age and performance status were consistent across both groups, while Serous histology was more prominent in group B. Although operative metrics and collaborative endeavours exhibited no statistically significant variance, the attainment of optimal debulking with no residual disease (R0) was substantially higher in group A (100%) compared to group B (54%), with a significance level of <em>P</em> = 0.05.</div></div><div><h3>Conclusion</h3><div>CT-based 3D modelling in the preoperative phase of SCS for ovarian cancer shows potential for enhancing surgical planning. While this pioneering research highlights the potential benefits of integrating 3D imaging into gynaecologic oncology, the limitations of this retrospective study imply that these findings are primarily hypothesis-generating. Further prospective studies are necessary to validate the impact.</div></div>","PeriodicalId":16688,"journal":{"name":"Journal of obstetrics and gynaecology Canada","volume":"47 1","pages":"Article 102714"},"PeriodicalIF":2.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142640412","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Risks and Outcomes of Uterine Rupture in Women With and Without a Trial of Labour 子宫破裂的风险和结果在妇女有和没有试产。

IF 2 Q2 OBSTETRICS & GYNECOLOGY

Journal of obstetrics and gynaecology Canada

Pub Date : 2025-01-01 DOI: 10.1016/j.jogc.2024.102718

Ohad Houri MD , Or Bercovich MD , Avital Wertheimer MD , Alexandra Berezowsky MD , Gil Zeevi MD , Shir Danieli-Gruber MD , Eran Hadar MD

Objectives

The study aimed to evaluate the maternal and neonatal outcomes in patients who experienced uterine rupture, comparing those who underwent a trial of labour to those who did not.

Methods

A population-based retrospective study was conducted in a tertiary university medical centre from 2008 to 2019. The cohort consisted of all women who were diagnosed with uterine rupture during cesarean delivery (CD) or laparotomy. Patients with 1 previous CD who underwent a trial of labour (TOLAC group) were compared against patients who had a history of CD in whom no trial of labour occurred, and/or against patients who had no prior CD in whom a ruptured uterus was diagnosed during or following delivery (no-TOLAC group). Patients with uterine scar dehiscence were excluded.

Results

Of 103 542 women who gave birth during the study period, 10 325 had a previous CD. Uterine rupture occurred in 95 cases: 55 among patients who had undergone TOLAC (0.98%) and 40 (0.85%) without trial of labour. Compared with the TOLAC group, the subgroup of women with a single prior CD who did not attempt TOLAC (n = 16) had a higher rate of neonatal intensive care unit admission (56.3% vs. 21.7%, OR 4.15; 95% CI 1.3–13.3, P = 0.01) and adverse composite maternal outcomes (blood transfusion, urinary bladder injury, and/or intensive care unit admission) (75% vs. 30.9%, OR 6.7; 95% CI 1.8–23.8, P < 0.01). There was no neonatal or maternal death in any group.

Conclusions

Despite the higher incidence of uterine rupture in women undergoing TOLAC, outcomes are less favourable when rupture occurs outside the trial of labour and if the uterus is unscarred.

目的：本研究旨在评估子宫破裂患者的产妇和新生儿结局，比较那些进行了分娩试验的患者和那些没有进行分娩试验的患者。方法：2008 - 2019年在某高等院校医学中心进行人群回顾性研究。该队列包括所有在剖宫产（CD）或剖腹手术中被诊断为子宫破裂的妇女。曾经有过一次乳糜泻并经历过分娩试验的患者（TOLAC组）与有乳糜泻病史但没有分娩试验的患者和/或没有乳糜泻但在分娩过程中或分娩后诊断出子宫破裂的患者（no-TOLAC组）进行比较。排除子宫瘢痕裂开患者。结果：在研究期间分娩的103 542名妇女中，10 325名有既往CD。95例发生子宫破裂：55例接受TOLAC(0.98%)， 40例（0.85%）未进行分娩试验。与TOLAC组相比，未尝试TOLAC的单一既往CD妇女亚组（n = 16）新生儿重症监护病房住院率更高（56.3%比21.7%,OR 4.15, 95% CI 1.3-13.3, P = 0.01）和不良综合产妇结局（输血、膀胱损伤和/或重症监护病房住院）（75%比30.9%,OR 6.7, 95% CI 1.8-23.8, P < 0.01）。所有组均无新生儿或产妇死亡。结论：尽管TOLAC患者子宫破裂的发生率较高，但如果子宫破裂发生在分娩试验之外且子宫未损伤，则预后较差。

{"title":"Risks and Outcomes of Uterine Rupture in Women With and Without a Trial of Labour","authors":"Ohad Houri MD , Or Bercovich MD , Avital Wertheimer MD , Alexandra Berezowsky MD , Gil Zeevi MD , Shir Danieli-Gruber MD , Eran Hadar MD","doi":"10.1016/j.jogc.2024.102718","DOIUrl":"10.1016/j.jogc.2024.102718","url":null,"abstract":"<div><h3>Objectives</h3><div>The study aimed to evaluate the maternal and neonatal outcomes in patients who experienced uterine rupture, comparing those who underwent a trial of labour to those who did not.</div></div><div><h3>Methods</h3><div>A population-based retrospective study was conducted in a tertiary university medical centre from 2008 to 2019. The cohort consisted of all women who were diagnosed with uterine rupture during cesarean delivery (CD) or laparotomy. Patients with 1 previous CD who underwent a trial of labour (TOLAC group) were compared against patients who had a history of CD in whom no trial of labour occurred, and/or against patients who had no prior CD in whom a ruptured uterus was diagnosed during or following delivery (no-TOLAC group). Patients with uterine scar dehiscence were excluded.</div></div><div><h3>Results</h3><div>Of 103 542 women who gave birth during the study period, 10 325 had a previous CD. Uterine rupture occurred in 95 cases: 55 among patients who had undergone TOLAC (0.98%) and 40 (0.85%) without trial of labour. Compared with the TOLAC group, the subgroup of women with a single prior CD who did not attempt TOLAC (n = 16) had a higher rate of neonatal intensive care unit admission (56.3% vs. 21.7%, OR 4.15; 95% CI 1.3–13.3, <em>P</em> = 0.01) and adverse composite maternal outcomes (blood transfusion, urinary bladder injury, and/or intensive care unit admission) (75% vs. 30.9%, OR 6.7; 95% CI 1.8–23.8, <em>P</em> < 0.01). There was no neonatal or maternal death in any group.</div></div><div><h3>Conclusions</h3><div>Despite the higher incidence of uterine rupture in women undergoing TOLAC, outcomes are less favourable when rupture occurs outside the trial of labour and if the uterus is unscarred.</div></div>","PeriodicalId":16688,"journal":{"name":"Journal of obstetrics and gynaecology Canada","volume":"47 1","pages":"Article 102718"},"PeriodicalIF":2.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142752768","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Fertility Preservation and Infertility Treatment in Female Surgical Trainees in Alberta: A Survey of Trainee Knowledge, Attitudes, and Needs 艾伯塔省女性外科培训生的生育能力保存和不孕症治疗：对培训生知识、态度和需求的调查。

IF 2 Q2 OBSTETRICS & GYNECOLOGY

Journal of obstetrics and gynaecology Canada

Pub Date : 2025-01-01 DOI: 10.1016/j.jogc.2024.102731

Sylvie Bowden MD, Selphee Tang BSc, Amy Metcalfe PhD, Shu Foong MD

Objectives

This study aimed to describe fertility knowledge and views on family planning and fertility preservation/treatment among female surgical trainees in Alberta.

Methods

A voluntary, anonymous online survey was sent to surgical program coordinators in Alberta to forward to their respective trainees. Participants included surgical trainees from cardiac surgery, general surgery, neurosurgery, obstetrics and gynaecology, ophthalmology, orthopaedics, otolaryngology, plastic surgery, urology, and vascular surgery. Questions assessed demographics, fertility knowledge, reproductive history, family planning views, and attitudes towards fertility preservation/treatment. The primary outcome were the needs of trainees regarding fertility preservation/treatment. Secondary outcomes included fertility knowledge, reproductive history, family planning views, and attitudes towards fertility preservation/treatment.

Results

The survey had a 71.8% response rate, with 125 responses analyzed. The median score for fertility knowledge was 3 out of 6. Most trainees (84.8%) were childless, with 68.0% citing career impact as a significant factor in delaying child-bearing. Career aspirations, training duration, and long work hours were identified as top factors impacting family planning. Only 3.2% had undergone oocyte cryopreservation, while 48.0% had considered it. Awareness of oocyte cryopreservation options and insurance coverage was low. During their training, 57.6% of trainees had received no counselling about family planning.

Conclusions

Female surgical trainees in Alberta face significant fertility concerns, exacerbated by gaps in fertility knowledge and career demands delaying child-bearing. There is strong interest in fertility preservation, but barriers include lack of awareness, financial constraints, and inadequate counselling. Enhanced education, counselling, insurance coverage, and supportive policies are needed to support trainees’ reproductive and career goals.

目的：了解艾伯塔省女性外科实习生的生育知识和对计划生育和生育保护/治疗的看法。方法：将一份自愿的匿名在线调查发送给艾伯塔省的外科项目协调员，并将其转发给各自的学员。参加者包括来自心脏外科、普通外科、神经外科、妇产科、眼科、骨科、耳鼻喉科、整形外科、泌尿外科和血管外科的外科学员。问题评估了人口统计、生育知识、生育史、计划生育观点和对生育保护/治疗的态度。主要结果是受训者对保存/治疗生育能力的需要。次要结局包括生育知识、生育史、计划生育观点和对生育保存/治疗的态度。结果：调查回复率为71.8%，共分析125份问卷。生育知识得分中位数为3/6。大多数学员（84.8%）没有孩子，其中68.0%认为职业影响是推迟生育的重要因素。职业抱负、培训时间和长工作时间被认为是影响计划生育的主要因素。接受卵母细胞冷冻保存的患者仅占3.2%，考虑冷冻保存的患者占48.0%。对卵母细胞冷冻保存选择和保险覆盖率的认识较低。57.6%的学员在培训期间未接受计划生育咨询。结论：艾伯塔省女性外科培训生面临严重的生育问题，生育知识差距和职业要求推迟生育加剧了这一问题。人们对保留生育能力有浓厚的兴趣，但障碍包括缺乏意识、经济限制和咨询不足。需要加强教育、咨询、保险覆盖面和支持性政策，以支持受训者的生殖和职业目标。

{"title":"Fertility Preservation and Infertility Treatment in Female Surgical Trainees in Alberta: A Survey of Trainee Knowledge, Attitudes, and Needs","authors":"Sylvie Bowden MD, Selphee Tang BSc, Amy Metcalfe PhD, Shu Foong MD","doi":"10.1016/j.jogc.2024.102731","DOIUrl":"10.1016/j.jogc.2024.102731","url":null,"abstract":"<div><h3>Objectives</h3><div>This study aimed to describe fertility knowledge and views on family planning and fertility preservation/treatment among female surgical trainees in Alberta.</div></div><div><h3>Methods</h3><div>A voluntary, anonymous online survey was sent to surgical program coordinators in Alberta to forward to their respective trainees. Participants included surgical trainees from cardiac surgery, general surgery, neurosurgery, obstetrics and gynaecology, ophthalmology, orthopaedics, otolaryngology, plastic surgery, urology, and vascular surgery. Questions assessed demographics, fertility knowledge, reproductive history, family planning views, and attitudes towards fertility preservation/treatment. The primary outcome were the needs of trainees regarding fertility preservation/treatment. Secondary outcomes included fertility knowledge, reproductive history, family planning views, and attitudes towards fertility preservation/treatment.</div></div><div><h3>Results</h3><div>The survey had a 71.8% response rate, with 125 responses analyzed. The median score for fertility knowledge was 3 out of 6. Most trainees (84.8%) were childless, with 68.0% citing career impact as a significant factor in delaying child-bearing. Career aspirations, training duration, and long work hours were identified as top factors impacting family planning. Only 3.2% had undergone oocyte cryopreservation, while 48.0% had considered it. Awareness of oocyte cryopreservation options and insurance coverage was low. During their training, 57.6% of trainees had received no counselling about family planning.</div></div><div><h3>Conclusions</h3><div>Female surgical trainees in Alberta face significant fertility concerns, exacerbated by gaps in fertility knowledge and career demands delaying child-bearing. There is strong interest in fertility preservation, but barriers include lack of awareness, financial constraints, and inadequate counselling. Enhanced education, counselling, insurance coverage, and supportive policies are needed to support trainees’ reproductive and career goals.</div></div>","PeriodicalId":16688,"journal":{"name":"Journal of obstetrics and gynaecology Canada","volume":"47 1","pages":"Article 102731"},"PeriodicalIF":2.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142776256","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Effect of Olanzapine on Hyperemesis Gravidarum in Individuals With Mood Disorders: A Case Series 奥氮平对情绪障碍患者妊娠剧吐的影响：一个病例系列。

IF 2 Q2 OBSTETRICS & GYNECOLOGY

Journal of obstetrics and gynaecology Canada

Pub Date : 2025-01-01 DOI: 10.1016/j.jogc.2024.102751

Verinder Sharma MBBS , Katelyn N. Wood PhD

This case series examines the effect of olanzapine on symptoms of hyperemesis gravidarum in individuals with mood disorders. Patient charts from 2022 to 2024 were reviewed, focusing on those with hyperemesis gravidarum who were treated with olanzapine alone or with other psychotropic drugs for their mood disorder. Of 6 patients with hyperemesis gravidarum, 3 had bipolar II disorder, and the others had major depressive disorder. Olanzapine was used alone in 3 cases. A daily dose of 2.5–5 mg was well tolerated and effective in all patients who had failed trials of conventional antiemetics. Thus, olanzapine may be a viable treatment for hyperemesis gravidarum in mood disorder patients unresponsive to standard antiemetics.

本病例系列探讨奥氮平对情绪障碍患者妊娠剧吐症状的影响。回顾了2022年至2024年的患者图表，重点关注那些因情绪障碍而单独使用奥氮平或其他精神药物治疗的妊娠剧吐患者。6例妊娠剧吐患者中，3例合并双相情感障碍，其余为重度抑郁障碍。单独使用奥氮平3例。在所有常规止吐药试验失败的患者中，每日2.5- 5mg的剂量耐受性良好且有效。因此，奥氮平可能是治疗对标准止吐药无反应的心境障碍患者妊娠剧吐的可行方法。

引用次数: 0

Test or No-Test: Comparison of Medication Abortion Outcomes and Adverse Events When Forgoing Ultrasound, Laboratory Testing, and Physical Examination 检查或不检查：放弃超声、实验室检查和体格检查时药物流产结局和不良事件的比较。

IF 2 Q2 OBSTETRICS & GYNECOLOGY

Journal of obstetrics and gynaecology Canada

Pub Date : 2025-01-01 DOI: 10.1016/j.jogc.2024.102730

Caitlin Hunter MD, CCFP , Maya Burck BA , Colleen Chambers MSc , Farhana Shawon MD , M. Ruth Lavergne PhD , Amanda Whitten MA, MD, CCFP , Mei-ling Wiedmeyer MD, CCFP, MSc

Objectives

This study aimed to compare demographics and clinical outcomes between patients who did not undergo investigations and those who underwent investigations before receiving a prescription for medication abortion (MA) during the first 6 months of the COVID-19 pandemic. Outcomes include success rates, adverse events, pathways to completion, and loss to follow-up rates.

Methods

We conducted a retrospective medical record review of 1452 patients presenting for MA between 23 March 2020 and 30 September 2020. Descriptive statistics, 2 × 2 chi-square tests, and Fisher exact tests were used to compare characteristics and outcomes between groups.

Results

Of the 1307 patients who received a prescription, 895 (68.5%) were in the no-test group and 412 (31.5%) were in the test group. The success rate was 95.2%, with no significant difference between groups (94.0% and 95.8%, P = 0.194). Rates of adverse events were low, with 28 patients presenting for emergency department visits (2.1%), 62 having clinically significant retained products of conception (4.7%), 5 with heavy bleeding requiring treatment (0.4%), 16 with ongoing pregnancy (1.2%), and 3 requiring ectopic pregnancy management (0.2%). Completion of abortion was verified in 1034 patients (80.5%), and the loss to follow-up rate was 22.6%, with no difference between the groups (82.1% vs. 79.8%, P = 0.341; and 21.4% vs. 23.1%, P = 0.477; respectively).

Conclusions

We found that clinical outcomes were consistent across the 2 groups, with high success rates and low adverse event rates. Our study contributes to the growing body of evidence that allows for individualized care implementing selective use of low- and no-test MA protocols.

目的：比较COVID-19大流行前6个月未接受调查的患者与接受药物流产（MA）处方前接受调查的患者的人口统计学和临床结果。结果包括成功率、不良事件、完成途径和失访率。方法：我们对2020年3月23日至2020年9月30日期间出现MA的1452例患者进行了回顾性图表回顾。描述性统计、2×2卡方检验和Fisher精确检验用于组间特征和结果的比较。结果：1307例处方患者中，未试验组895例（68.5%），试验组412例（31.5%）。成功率为95.2%，两组间差异无统计学意义（94.0%,95.8%,P = 0.194）。不良事件发生率较低，有28例患者就诊于急诊室（2.1%），62例有临床意义的妊娠残留（4.7%），5例需要治疗的大出血（0.4%），16例正在妊娠（1.2%），3例需要异位处理（0.2%）。流产完成1034例（80.5%），失访率为22.6%，两组间差异无统计学意义（82.1%∶79.8%,P = 0.341; 21.4%∶23.1%,P = 0.477）。结论：我们发现两组临床结果一致，成功率高，不良事件发生率低。我们的研究为个性化护理提供了越来越多的证据，这些证据可以选择性地使用低测试和无测试的MA协议。

{"title":"Test or No-Test: Comparison of Medication Abortion Outcomes and Adverse Events When Forgoing Ultrasound, Laboratory Testing, and Physical Examination","authors":"Caitlin Hunter MD, CCFP , Maya Burck BA , Colleen Chambers MSc , Farhana Shawon MD , M. Ruth Lavergne PhD , Amanda Whitten MA, MD, CCFP , Mei-ling Wiedmeyer MD, CCFP, MSc","doi":"10.1016/j.jogc.2024.102730","DOIUrl":"10.1016/j.jogc.2024.102730","url":null,"abstract":"<div><h3>Objectives</h3><div>This study aimed to compare demographics and clinical outcomes between patients who did not undergo investigations and those who underwent investigations before receiving a prescription for medication abortion (MA) during the first 6 months of the COVID-19 pandemic. Outcomes include success rates, adverse events, pathways to completion, and loss to follow-up rates.</div></div><div><h3>Methods</h3><div>We conducted a retrospective medical record review of 1452 patients presenting for MA between 23 March 2020 and 30 September 2020. Descriptive statistics, 2 × 2 chi-square tests, and Fisher exact tests were used to compare characteristics and outcomes between groups.</div></div><div><h3>Results</h3><div>Of the 1307 patients who received a prescription, 895 (68.5%) were in the no-test group and 412 (31.5%) were in the test group. The success rate was 95.2%, with no significant difference between groups (94.0% and 95.8%, <em>P</em> = 0.194). Rates of adverse events were low, with 28 patients presenting for emergency department visits (2.1%), 62 having clinically significant retained products of conception (4.7%), 5 with heavy bleeding requiring treatment (0.4%), 16 with ongoing pregnancy (1.2%), and 3 requiring ectopic pregnancy management (0.2%). Completion of abortion was verified in 1034 patients (80.5%), and the loss to follow-up rate was 22.6%, with no difference between the groups (82.1% vs. 79.8%, <em>P</em> = 0.341; and 21.4% vs. 23.1%, <em>P</em> = 0.477; respectively).</div></div><div><h3>Conclusions</h3><div>We found that clinical outcomes were consistent across the 2 groups, with high success rates and low adverse event rates. Our study contributes to the growing body of evidence that allows for individualized care implementing selective use of low- and no-test MA protocols.</div></div>","PeriodicalId":16688,"journal":{"name":"Journal of obstetrics and gynaecology Canada","volume":"47 1","pages":"Article 102730"},"PeriodicalIF":2.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142776257","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Association of Acute Histological Chorioamnionitis and Other Placental Lesions With Subsequent Pregnancy Outcomes After Spontaneous Preterm Birth 急性组织学绒毛膜羊膜炎和其他胎盘病变与自然早产后妊娠结局的关系。

IF 2 Q2 OBSTETRICS & GYNECOLOGY

Journal of obstetrics and gynaecology Canada

Pub Date : 2025-01-01 DOI: 10.1016/j.jogc.2024.102715

Ludmila Porto MD, MSc , Nir Melamed MD, MSc , Jessica Liu MD , John Kingdom MD , John Snelgrove MD, MSc , Elizabeth Aztalos MD, MSc , Christopher Sherman MD , Jon Barrett MD , Stefania Ronzoni MD, PhD

Objectives

Acute histological chorioamnionitis (HCA) is detected in over 50% of spontaneous preterm birth (PTB) and is associated with worse neonatal prognosis. We aim to investigate whether the presence of HCA impacts subsequent pregnancy outcomes.

Methods

This retrospective cohort study included deliveries at a tertiary centre from 2014 to 2020. Participants were individuals with a history of spontaneous PTB or pregnancy loss >16⁰ weeks and available placental pathology (index pregnancy) with a subsequent pregnancy followed at the same institution. Placentas were classified according to the presence of HCA, other placental lesions, or no lesions. Subsequent pregnancy outcomes were analyzed. The primary outcome was the rate of overall and spontaneous PTB (<37⁰ weeks) in the subsequent pregnancy.

Results

A total of 292 individuals met the study criteria, of which 133 had HCA, 61 had other placental lesions, and 98 had no lesions. Individuals with HCA in the index delivery had a higher risk of PTB <28⁰ weeks in the subsequent pregnancy, compared to the no-lesion group (10.4% vs. 1.0%, P = 0.004). Rates of PTB >28⁰ weeks did not significantly differ. The risk of neonatal adverse composite outcomes was higher in the HCA group (13.9% vs. 4.2%, P < 0.01). In a subanalysis of different placental lesions at the index PTB, only maternal vascular malperfusion was associated with recurrent PTB (adjusted odds ratio 2.57, P = 0.01).

Conclusions

PTB with HCA is associated with higher rates of extreme PTB and adverse neonatal outcomes in the subsequent pregnancy. The inclusion of placental pathology analysis may improve individualized risk assessment in future pregnancies.

目的：急性组织学绒毛膜羊膜炎（HCA）在50%以上的自发性早产（PTB）中被检测到，并且与新生儿预后不良有关。我们的目的是调查 HCA 的存在是否会影响随后的妊娠结局：这项回顾性队列研究纳入了 2014 年至 2020 年在一家三级医疗中心的分娩情况。参与者为有自发性PTB病史或妊娠损失大于16周且有胎盘病理（指数妊娠）并在同一机构接受后续妊娠随访的个体。根据是否存在 HCA、其他胎盘病变或无病变对胎盘进行分类。对后续妊娠结果进行分析。主要结果是总体和自发性PTB的发生率（结果：共有 292 人符合研究标准，其中 133 人有 HCA，61 人有其他胎盘病变，98 人无病变。预产期为 28 周的 HCA 患儿发生 PTB 的风险较高，但无明显差异。HCA组发生新生儿不良综合结局的风险更高（13.9% vs 4.2%，P < 0.01）。在对指数PTB时不同胎盘病变的子分析中，只有母体血管灌注不良与复发性PTB相关（aOR 2.57，P = 0.01）：结论：伴有HCA的PTB与较高的极端PTB发生率及后续妊娠的不良新生儿结局相关。纳入胎盘病理学分析可改善未来妊娠的个体化风险评估。

{"title":"Association of Acute Histological Chorioamnionitis and Other Placental Lesions With Subsequent Pregnancy Outcomes After Spontaneous Preterm Birth","authors":"Ludmila Porto MD, MSc , Nir Melamed MD, MSc , Jessica Liu MD , John Kingdom MD , John Snelgrove MD, MSc , Elizabeth Aztalos MD, MSc , Christopher Sherman MD , Jon Barrett MD , Stefania Ronzoni MD, PhD","doi":"10.1016/j.jogc.2024.102715","DOIUrl":"10.1016/j.jogc.2024.102715","url":null,"abstract":"<div><h3>Objectives</h3><div>Acute histological chorioamnionitis (HCA) is detected in over 50% of spontaneous preterm birth (PTB) and is associated with worse neonatal prognosis. We aim to investigate whether the presence of HCA impacts subsequent pregnancy outcomes.</div></div><div><h3>Methods</h3><div>This retrospective cohort study included deliveries at a tertiary centre from 2014 to 2020. Participants were individuals with a history of spontaneous PTB or pregnancy loss >16<sup>0</sup> weeks and available placental pathology (index pregnancy) with a subsequent pregnancy followed at the same institution. Placentas were classified according to the presence of HCA, other placental lesions, or no lesions. Subsequent pregnancy outcomes were analyzed. The primary outcome was the rate of overall and spontaneous PTB (<37<sup>0</sup> weeks) in the subsequent pregnancy.</div></div><div><h3>Results</h3><div>A total of 292 individuals met the study criteria, of which 133 had HCA, 61 had other placental lesions, and 98 had no lesions. Individuals with HCA in the index delivery had a higher risk of PTB <28<sup>0</sup> weeks in the subsequent pregnancy, compared to the no-lesion group (10.4% vs. 1.0%, <em>P</em> = 0.004). Rates of PTB >28<sup>0</sup> weeks did not significantly differ. The risk of neonatal adverse composite outcomes was higher in the HCA group (13.9% vs. 4.2%, <em>P</em> < 0.01). In a subanalysis of different placental lesions at the index PTB, only maternal vascular malperfusion was associated with recurrent PTB (adjusted odds ratio 2.57, <em>P</em> = 0.01).</div></div><div><h3>Conclusions</h3><div>PTB with HCA is associated with higher rates of extreme PTB and adverse neonatal outcomes in the subsequent pregnancy. The inclusion of placental pathology analysis may improve individualized risk assessment in future pregnancies.</div></div>","PeriodicalId":16688,"journal":{"name":"Journal of obstetrics and gynaecology Canada","volume":"47 1","pages":"Article 102715"},"PeriodicalIF":2.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142696281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

2024 Index of SOGC Clinical Practice Guidelines

IF 2 Q2 OBSTETRICS & GYNECOLOGY

Journal of obstetrics and gynaecology Canada

Pub Date : 2025-01-01 DOI: 10.1016/j.jogc.2024.102748

引用次数: 0

Bilateral Salpingitis Isthmica Nodosa: A Laparoscopic Clue Supporting its Infectious Etiology 双侧结节性输卵管炎：腹腔镜线索支持其感染性病因。

IF 2 Q2 OBSTETRICS & GYNECOLOGY

Journal of obstetrics and gynaecology Canada

Pub Date : 2025-01-01 DOI: 10.1016/j.jogc.2024.102717

Konstantinos Koukoumpanis MD, MSc, Michail Panagiotopoulos MD, MSc, Athanasios Douligeris MD, MSc, Konstantinos Kypriotis MD, MSc, Nikolaos Kathopoulis MD, MSc, PhD, Athanasios Protopapas MD, PhD

引用次数: 0

Placenta Accreta Spectrum Disorders: A Canadian Tertiary Care Centre’s Experience Over 10 years 胎盘增生谱系障碍：加拿大三级保健中心的经验超过10年。

IF 2 Q2 OBSTETRICS & GYNECOLOGY

Journal of obstetrics and gynaecology Canada

Pub Date : 2024-12-31 DOI: 10.1016/j.jogc.2024.102757

Catherine Lu MD , Carol Schneider MD , Caroline Corbett MD , Anet Maksymowicz MD , Devon Evans MD

Objectives

The placenta accreta spectrum disorders (PASD) are associated with significant maternal and neonatal morbidity and mortality worldwide. As cesarean delivery rates increase, so does the rate of PASD. PASD antepartum diagnosis and perioperative management are evolving, and we primarily aimed to share our tertiary care centre’s institutional approach and outcomes over a decade.

Methods

A retrospective medical record review of cesarean hysterectomy for suspected or confirmed PASD was conducted at a single tertiary centre in Canada from 2010 to 2021.

Results

A total of 46 records remained after applying the exclusion criteria, with a diagnosis of PASD in 94% of cases, and 20% consistent with accreta, 48% with increta, and 26% with percreta. Cesarean hysterectomies were conducted on an unscheduled emergency basis in 41% of cases. All cases had antenatal ultrasound imaging, and 57% received an antenatal MRI. Prophylactic ureteric stenting occurred in 37% of cases. Mean total operative time was 97 minutes, and 50% of cases received an intraoperative blood transfusion. Ureteric injury occurred in 2% of cases, and admission to the intensive care unit in 13% of cases.

Conclusions

PASD is a complex and highly morbid condition. We have shared our institutional experience and explored some variations in practice, including the use of prophylactic ureteric stenting. Additional research is needed to further explore the optimal methods to diagnose and manage this complex disorder.

目的：胎盘增生谱系障碍（PASD）与全球孕产妇和新生儿的发病率和死亡率相关。随着剖宫产率的增加，PASD的发生率也在增加。产前诊断和围手术期管理正在不断发展，我们的主要目标是分享我们三级护理中心十年来的机构方法和成果。方法：回顾性分析2010年至2021年XXX某三级中心剖宫产子宫切除术疑似或确诊PASD的病例。结果：在排除标准后，总共保留了46例记录，其中94%的病例诊断为PASD， 20%符合accreta， 48%符合increta， 26%符合percreta。41%的剖宫产子宫切除术是在计划外的紧急情况下进行的。所有病例进行了产前超声成像，57%的患者接受了产前MRI检查。预防性输尿管支架置入术发生率为37%。平均总手术时间为97分钟，50%的病例接受术中输血。输尿管损伤发生率为2%，住院率为13%。结论：PASD是一种复杂的、高度病态的疾病。我们分享了我们的机构经验，并探讨了实践中的一些变化，包括使用预防性输尿管支架置入。需要进一步的研究来进一步探索诊断和管理这种复杂疾病的最佳方法。

{"title":"Placenta Accreta Spectrum Disorders: A Canadian Tertiary Care Centre’s Experience Over 10 years","authors":"Catherine Lu MD , Carol Schneider MD , Caroline Corbett MD , Anet Maksymowicz MD , Devon Evans MD","doi":"10.1016/j.jogc.2024.102757","DOIUrl":"10.1016/j.jogc.2024.102757","url":null,"abstract":"<div><h3>Objectives</h3><div>The placenta accreta spectrum disorders (PASD) are associated with significant maternal and neonatal morbidity and mortality worldwide. As cesarean delivery rates increase, so does the rate of PASD. PASD antepartum diagnosis and perioperative management are evolving, and we primarily aimed to share our tertiary care centre’s institutional approach and outcomes over a decade.</div></div><div><h3>Methods</h3><div>A retrospective medical record review of cesarean hysterectomy for suspected or confirmed PASD was conducted at a single tertiary centre in Canada from 2010 to 2021.</div></div><div><h3>Results</h3><div>A total of 46 records remained after applying the exclusion criteria, with a diagnosis of PASD in 94% of cases, and 20% consistent with accreta, 48% with increta, and 26% with percreta. Cesarean hysterectomies were conducted on an unscheduled emergency basis in 41% of cases. All cases had antenatal ultrasound imaging, and 57% received an antenatal MRI. Prophylactic ureteric stenting occurred in 37% of cases. Mean total operative time was 97 minutes, and 50% of cases received an intraoperative blood transfusion. Ureteric injury occurred in 2% of cases, and admission to the intensive care unit in 13% of cases.</div></div><div><h3>Conclusions</h3><div>PASD is a complex and highly morbid condition. We have shared our institutional experience and explored some variations in practice, including the use of prophylactic ureteric stenting. Additional research is needed to further explore the optimal methods to diagnose and manage this complex disorder.</div></div>","PeriodicalId":16688,"journal":{"name":"Journal of obstetrics and gynaecology Canada","volume":"47 3","pages":"Article 102757"},"PeriodicalIF":2.0,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142924384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

SOGC Guideline Retirement Notice No. 10 公司指引退休通知书第10号

IF 2 Q2 OBSTETRICS & GYNECOLOGY

Journal of obstetrics and gynaecology Canada

Pub Date : 2024-12-01 DOI: 10.1016/j.jogc.2024.102737

引用次数: 0

首页上一页

下一页尾页

类型

全部化学•材料生命科学医学物理工程技术环境•农林材料科学地球科学法学管理学化学环境科学与生态学计算机科学教育学经济学农林科学人文科学生物学数学物理与天体物理心理学综合性期刊其他工业工程理学历史学农学文学信息工程

数据库

全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley

期刊

Journal of obstetrics and gynaecology Canada

全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.

﹀